ABSTRACT
Objective@#To investigate the effects of apoptotic bodies (ABs) derived from dental pulp stem cells (DPSCs) on macrophage polarization and inflammation response in vivo. @*Methods @#Human DPSCs were extracted, cultured and identified. Staurosporine was used to apoptosis induction and differential methods were performed for ABs identification. The in vitro cultured macrophages were divided into 3 groups: solvent control, lipopolysaccharide (LPS), and the LPS+ABs. The macrophages were stimulated with LPS to induce inflammation followed by ABs treatment. In the untreated group, macrophages were added with an equal amount of solvent. The specific uptake of ABs by macrophages, the expression level of CD206 and the levels of inflammatory cytokines were analyzed. The mouse models of cutaneous wounds and dextran sulfate sodium (DSS)-induced colitis were established, and the mice were randomly divided into 3 groups: the PBS-treated group, the DPSCs-treated group, and the ABs-treated group. The mice were injected with the same volume of PBS, DPSCs and ABs, respectively. The body weight, histological pathology, the expression levels of CD206 and cytokines, and the extent of tissue regeneration were measured.@* Results @#DPSCs and ABs derived from DPSCs were successfully isolated and characterized. ABs could be taken up by macrophage. While lipopolysaccharide(LPS) induced production of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), ABs significantly reduced the levels of these pro-inflammatory cytokines and increased the expression of transforming growth factor-β (TGF-β) and CD206 (P < 0.01). In the cutaneous inflammatory wound model, the wound closure rate in mice intravenously injected with ABs was significantly accelerated (P < 0.05). The administration of ABs markedly reduced the pro-inflammatory factors levels and increased the CD206+ cell number. In the colitis model, treatment with ABs markedly reduced the loss in bodyweight (P < 0.05), recovered the colon length (P < 0.01), and significantly increased the CD206+ cell number.@* Conclusion@# DPSCs-derived ABs could enhance macrophage M2 polarization and attenuate inflammation. Therefore, ABs could be used as a promising cell replacement for inflammatory regulation and tissue regeneration.
ABSTRACT
In recent years, extracellular vesicles are found as an important medium for intercellular signal communication in prokaryotic and higher eukaryotic cells for regulating a variety of biological processes.Extracellular vesi-cles include exosomes,microvesicles and apoptotic bodies,and can be released into extracellular media by almost all types of cells in vivo and in vitro.Extracellular vesicles are released under physiological and pathological conditions, including liver diseases,and have a wide range of effects on the target cells.This review summarizes the progress in understanding the role of extracellular vesicles in chronic liver diseases.Specifically, how extracellular vesicles regulate non-alcoholic steatohepatitis,alcoholic liver disease, viral hepatitis, liver fibrosis and hepatocellular carcinoma is discussed in detail highlighting extracellular vesicles as a promising therapeutic target for chronic liver diseases.
ABSTRACT
This study was aimed to observe the effect of Bushen-Huoxue-Tonglin formula (BSHXTLF) on Ki-67 and apoptotic bodies in benign prostatic hyperplasia (BPH) rats. A total of 72 Wistar rats were randomly divided into 6 groups, which were the sham operation group, model group, Proscar group (0.8 mg?kg-1), BSHXTLF groups with low, middle and high dose (7.5, 15, 22.5 g?kg-1). Except the sham operation group, the BPH model was established by injecting testosterone propionate (5 mg?kg-1) for 30 days after removing both testicles in the rats. The drugs were administrated once a day for 30 days at the same time. The immunohistochemical and TUNEL methods were used to determine Ki-67 and apoptotic bodies, respectively. The results showed that compared with the model group , the expression of Ki-67 in treatment groups was decreased ( P < 0 . 05 ) . Compared with Proscar group and low-dose BSHXTLF group, the expression of Ki-67 in the middle- and high-dose BSHXTLF group was decreased ( P < 0 . 05 ) . Compared with the middle-dose BSHXTLF group , the expression of Ki-67 in the high-dose BSHXTLF group was decreased ( P < 0 . 05 ) . Compared with the model group , the expression of apoptot-ic bodies in each treatment group was increased ( P < 0 . 05 ) . Compared with Proscar group , low-dose and middle-dose BSHXTLF group, the expression of apoptotic bodies in the high-dose BSHXTLF group was increased (P <0.05). It was concluded that BSHXTLF may decrease the expression of Ki-67 and increase the expression of apoptotic bodies in BPH rats. These results provided objective evidences for clinical treatment of BPH.